Additionally, the hypermethylation of the -132 site in the PEMT promoter occurs in breast cancer type 1 susceptibility gene (BRCA1)-mutated breast cancer cells [38], resulting in reduced enzyme expression. The gene discussed is PEMT; the disease is breast cancer.